NCT03201887

Brief Summary

Performance Validity Tests (PVTs) are widely used for the detection of sub-optimal effort and malingering in neuropsychological assessments. Threats to their validity however likely to intensify with time (e.g., information available on the web or from legal representatives) and may lead to a decline in their ability to differentiate between malingerers and non-malingerers. Eye movements and response time (RT) are less obvious outcome measures and under less conscious control than more conventional PVT indices (e.g., accuracy). They are therefore promising measures that can aid in detecting malingering when used in conjunction with more conventional PVT indices. The Word Memory Test (WMT) is a widely used PVT in neuropsychological evaluations. As part of the proposed study, TBI patients, chronic pain patients and healthy adults (60 in each group) will be randomly divided to one of two conditions; optimal effort or sub-optimal effort (participants will be asked to play a TBI patient who wishes to present himself as having cognitive deficits or exaggerate existing cognitive deficits). The proposed study will improve the WMT's efficacy in detection of sub-optimal effort in neuropsychological evaluations and therefore protect its validity from future threats. In addition, the proposed study will provide us with better understanding of the effect of TBI on eye movements and RTs in general.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2017

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2017

Completed
5 months until next milestone

First Posted

Study publicly available on registry

June 28, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

July 1, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

June 28, 2017

Status Verified

January 1, 2017

Enrollment Period

1.5 years

First QC Date

January 17, 2017

Last Update Submit

June 26, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Eye Movements

    Eye tracking used to evaluate eye behavior.

    1 month

Study Arms (4)

Sub-optimal Traumatic Brain Injury

EXPERIMENTAL

Sub-optimal effort

Behavioral: Sub-optimal effortBehavioral: optimal effort

Sub-optimal effort Chronic pain

EXPERIMENTAL

Sub-optimal effort

Behavioral: Sub-optimal effortBehavioral: optimal effort

Traumatic Brain Injury

NO INTERVENTION

optimal effort

Chronic pain

NO INTERVENTION

optimal effort

Interventions

Participants will be asked to play a patient who wishes to present himself as having cognitive deficits or exaggerate existing cognitive deficits

Also known as: Simulation condition
Sub-optimal Traumatic Brain InjurySub-optimal effort Chronic pain
optimal effortBEHAVIORAL

Participants will be asked to perform tasks to the best of their abilities.

Also known as: control condition
Sub-optimal Traumatic Brain InjurySub-optimal effort Chronic pain

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (18-65) female and males.
  • Signed informed consent form.
  • TBI of at least mild severity, as operationalized by Post traumatic amnesia (PTA) \< 24 hours
  • Glasgow coma scale (GCS) of 13-15
  • Loss of consciousness (LOC) of 30 minutes or less.
  • Pain without apparent biological value that has persisted beyond three months. This will be based on the participant self-report, electronic medical records and consultation with treating physician.

You may not qualify if:

  • Any current eye impairment (e.g., limited visual field, nystagmus, astigmatism \[cylinder\], strabismus or any other impairment specified by the participant), past strabismus, and refractive surgery.
  • Significant past neurological disorder/s and/or neurosurgery (special emphasis will be put on any language impairment such as aphasia).
  • Significant developmental disorders (e.g., learning disabilities such as dyslexia). (d)
  • Significant past or present psychiatric disorders (as evident, for example, in psychiatric inpatient hospitalization and past suicide attempts).
  • Significant current neurological disorder/s (special emphasis will be put on any language impairment such as aphasia) as decided by a joint consultation of the research team.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain Injuries, TraumaticChronic Pain

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Moti Ratmansky, MD

    Loewenstein Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Moti Ratmansky, MD

CONTACT

Yoram Braw, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2017

First Posted

June 28, 2017

Study Start

July 1, 2017

Primary Completion

January 1, 2019

Study Completion

January 1, 2019

Last Updated

June 28, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

We do not plan to share IPD